Review Article

Vitamin D and Its Relationship with Obesity and Muscle

Table 1

Effect of vitamin D on muscle strength and falls.

Author, year, and study typePatients, ageEndpoints/toolsResult

Visser et al., 2003 [73];
prospective
observational  
study
1008 for grip strength evaluation; 331 for muscle mass evaluation; 55–85 yrsGrip strength;  
appendicular skeletal muscle mass (using dual-energy X-ray absorptiometry)
(i) Persons with baseline 25-OHD levels <25 nmol/liter were 2.57 (based on grip strength) and 2.14 (based on muscle mass) times more likely to experience sarcopenia, compared with those with levels >50 nmol/liter 
(ii) PTH >4.0 pmol/liter was associated with an increased risk of sarcopenia

Latham et al., 2003 [101];  multicenter,  RCT*243 
hospitalized 
patients; 
65 yrs or older
Falls, physical performance (isometric knee extensor strength), and self-rated functionNo effect of vitamin D (calciferol, 300,000 IU) on physical health, falls, and physical performance, even in patients with baseline vitamin D levels <12 ng/mL

Kenny et al., 2003 [95];  RCT*65 healthy, community-dwelling men; 65–87 yrsUpper and lower extremity muscle strength and power (using a leg press and handgrip strength), physical performance (specific tests), and activity (using questionnaires)(i) Baseline 25OHD correlated with baseline single-leg stance time and physical activity score. Baseline PTH levels correlated with baseline 8-foot walk time and physical activity score 
(ii) No significant difference in strength, power, and physical performance between groups (cholecalciferol 1,000 IU/d or placebo for 6 months, all received 500 mg of calcium)

Broe et al., 2007 [75]; secondary data analysis of a previous RCT*124 nursing-home residents; 68–104 yrsFallsSupplementation with 800 IU of cholecalciferol reduced the adjusted-incidence rate ratio of falls by 72%, compared to placebo; no differences for the 200, 400, and 600 IU dose

Bischoff-Ferrari et al.,  2004 [78];  
population-based survey
Ambulatory population; 60–90 yrsLower-extremity function; timed 8-foot walk test; and repeated sit-to-stand testThe group in the highest quintiles of 25(OH)D had an average decrease of 0.27 s in the 8-foot walk test and an average decrease of 0.67 s in the sit-to-stand test

Gerdhem et
al., 2005 [77];
prospective
observational
study
986; 75.0–75.9 yrsGait, balance, and self-estimated activity level thigh muscle strength25OHD correlated with gait speed ( ), balance test ( ), self-estimated activity level ( ), and thigh muscle strength ( )

Houston et al., 2007 [81]; post hoc analysis of a prospective population-based study976; 65 yrs or olderShort physical performance battery (SPPB) and handgrip strength(i) Vitamin D levels were significantly associated with SPPB score in men ( ) and handgrip strength in men ( ) and women ( ) 
(ii) Men and women with serum 25OHD <25.0 nmol/L had significantly lower SPPB score; and those with serum 25OHD <50 nmol/L had significantly lower handgrip strength than those with serum 25OHD ≥25 and ≥50 nmol/L, respectively, ( ) 
(iii) PTH was significantly associated with handgrip strength only ( )

Pfeifer et al., 2009 [91];
double-blind, controlled trial
242
community-dwelling people; 70 yrs or older
Falls, body sway, timed-up-and-go test, and maximum isometric leg extensor strength (assessed with a strain gauge dynamometer)(i) Calcium plus vitamin D significantly decreased the number of subjects with first falls of 27% at month 12 and 39% at month 20, compared to calcium alone 
(ii) Significant improvements in quadriceps strength of 8%, a decrease in body sway of 28%, and a decrease in time needed to perform the TUG test of 11%

Moreira-Pfrimer et al., 2009 [92]; prospective, double-blind, placebo-controlled,
randomized trial
46 patients in long-stay geriatric care, 62–94 yearsMaximum isometric strength of hip flexors (SHF) and knee extensors (SKE), measured by a portable mechanical dynamometerSHF was increased in the calcium/vitamin D group (1 g calcium + cholecalciferol 150,000 IU once a month for the first 2 months and then 90,000 IU once a month for the last 4 months) by 16.4% ( ) and SKE by 24.6% ( ), no improvement in the calcium + placebo group

Kukuljan et al., 2009 [93]; RCT*180 healthy men, 50–79 yrsTotal body lean and fat mass (DXA), midfemur muscle cross-sectional area (quantitative computed tomography), muscle strength, and physical functionDaily consumption of low-fat fortified milk (providing 1000 mg calcium and 800 IU vitamin D3, per day) does not enhance the effects of resistance training exercise on skeletal muscle size, strength, or function

Bischoff-Ferrari et al., 2009 [96]; meta-analysis of RCT*2426 patients from 8 RCTFalls(i) High dose supplemental vitamin D reduced fall risk by 19%
(ii) Achieved serum 25 (OH)D concentrations of 60 nmol/L or more resulted in a 23% fall reduction

Lips et al., 2010 [94];
double-blind, placebo-controlled trial
126 patients with vitamin D insufficiency; 70 yrs or olderMediolateral body sway and short physical performance battery (SPPB)(i) After 16 wk, mediolateral sway and SPPB did not differ significantly between treatment groups (vitamin D3 8400 IU/week versus placebo) 
(ii) In the post hoc analysis treatment with vitamin D3 significantly reduced sway compared with placebo ( ) in patients with elevated baseline sway

Gupta et al., 2010 [90];
double-blind, randomized trial
40 healthy volunteers;
20–40 yrs
Handgrip and gastrosoleus dynamometry, pinch-grip strength, respiratory pressures, 6-minute walk test, and muscle energy
Metabolism on magnetic resonance spectroscopy
The supplemented group (60,000 IU D3/week for 8 weeks followed by 60,000 IU/month for 4 months + 1 g of calcium daily) gained a handgrip strength of 2Æ4 kg; gastrosoleus strength of 3Æ0 Nm; and walking distance of 15Æ9 m over the placebo group

Murad et al., 2011 [76];
meta-analysis
45,782 participants from 26 trialsFallsVitamin D use was associated with statistically significant reduction in the risk of falls (odds ratio for suffering at least one fall, 0.86; 95% confidence interval, 0.77–0.96)

Goswami et al., 2012 [99]; RCT*173 healthy females, mean age 21.7 + 4.4 yrsHandgrip and pinch grip strength and distance walked in 6 minMean handgrip strength and its increase were comparable in 4 groups (double placebo, calcium/placebo, cholecalciferol/placebo, and cholecalciferol/calcium at 6 months)

Cipriani et al., 2013 [100]; prospective
intervention
study
18 women with vitamin D deficiency
(25–39 yrs)
Handgrip strength (using a dynamometer and evaluating maximal voluntary contraction (MVC) and speed of contraction ( ))(i) No significant change in MVC and values after vitamin D supplementation (cholecalciferol 600,000 IU) 
(ii) A significant correlation between MVC and and serum phosphorus after supplementation ( and , resp.)

Knutsen et al., 2014 [98]; RCT*251 healthy adults with vitamin D deficiency (18–50 yrs)Jump height, handgrip strength, and chair-rising test(i) Percentage change in jump height did not differ between the group receiving vitamin D3 (1000 IU daily) and placebo ( )
(ii) No significant effect of vitamin D on handgrip strength or the chair-rising test

Randomized controlled trial.
Dual-energy X-ray absorptiometry.